| Vaccination of the population aged 60 years and older against COVID-19 is a cost-effective strategy compared with other strategies in the Danish vaccination programme. |
| Whether the vaccination programme against COVID-19 for the population younger than 60 years old is cost-effective depends on the price of the vaccine and the costs of its administration as well as the testing costs. |